Evidence map›Paper›PMID 20964857›Full record

ArticleBMC genomics2010

High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis.

Torben Friedrich, Sven Rahmann, Wilfried Weigel, Wolfgang Rabsch, Angelika Fruth, Eliora Ron, Florian Gunzer, Thomas Dandekar, Jörg Hacker, Tobias Müller and 1 more

Abstract read
In one paragraph

Article in BMC genomics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. International journal of general medicine · 2021
    Article
  4. Review
  5. Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Torben FriedrichUniversity of Würzburg, Institute for Molecular Infection Biology, Würzburg, Germany.
Sven Rahmann
Wilfried Weigel
Wolfgang Rabsch
Angelika Fruth
Eliora Ron
Florian Gunzer
Thomas Dandekar
Jörg Hacker
Tobias Müller
Ulrich Dobrindt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Enterobacteriaceae comprise a large number of clinically relevant species with several individual subspecies. Overlapping virulence-associated gene pools and the high overall genome plasticity often interferes with correct enterobacterial strain typing and risk assessment. Array technology offers a fast, reproducible and standardisable means for bacterial typing and thus provides many advantages for bacterial diagnostics, risk assessment and surveillance. The development of highly discriminative broad-range microbial diagnostic microarrays remains a challenge, because of marked genome plasticity of many bacterial pathogens.

resultsWe developed a DNA microarray for strain typing and detection of major antimicrobial resistance genes of clinically relevant enterobacteria. For this purpose, we applied a global genome-wide probe selection strategy on 32 available complete enterobacterial genomes combined with a regression model for pathogen classification. The discriminative power of the probe set was further tested in silico on 15 additional complete enterobacterial genome sequences. DNA microarrays based on the selected probes were used to type 92 clinical enterobacterial isolates. Phenotypic tests confirmed the array-based typing results and corroborate that the selected probes allowed correct typing and prediction of major antibiotic resistances of clinically relevant Enterobacteriaceae, including the subspecies level, e.g. the reliable distinction of different E. coli pathotypes.

conclusionsOur results demonstrate that the global probe selection approach based on longest common factor statistics as well as the design of a DNA microarray with a restricted set of discriminative probes enables robust discrimination of different enterobacterial variants and represents a proof of concept that can be adopted for diagnostics of a wide range of microbial pathogens. Our approach circumvents misclassifications arising from the application of virulence markers, which are highly affected by horizontal gene transfer. Moreover, a broad range of pathogens have been covered by an efficient probe set size enabling the design of high-throughput diagnostics.

Indexed as

Anti-Infective AgentsBacterial Typing TechniquesDecision TreesDNA, BacterialDNA ProbesDrug Resistance, BacterialEnterobacteriaceaeGenome, BacterialHigh-Throughput Screening AssaysMolecular Diagnostic TechniquesNucleic Acid HybridizationOligonucleotide Array Sequence AnalysisRegression AnalysisAnti-Infective AgentsDNA, BacterialDNA Probes

Identifiers

PMID20964857
PMCPMC3017858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.